HealthWarehouse.com Inc. (OTCMKTS:HEWA - Get Free Report) shares passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $0.12 and traded as high as $0.1473. HealthWarehouse.com shares last traded at $0.13, with a volume of 38,223 shares traded. HealthWarehouse.com Stock Performance The company's 50-day moving average
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com Reports Results for Third Quarter 2025; Reports 7% decline in sales due to slowing DTC sales and shifts in GLP-1 market.
CINCINNATI--(BUSINESS WIRE)--Healthwarehouse.com reports 182% Growth in Sales and $228,000 in Net Income for the Second Quarter of 2025.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2025, totaled $15.0 million, a 194% increase from the quarter ended March 31, 2024, resulting from 616% growth in partner services revenues. The Company reported net income of $178,000 and Adjusted EBITDA of $521,000 for the quarter. HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-th.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com Reports Full Year 2024 Results.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024. HealthWareho.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today its results of operations for the year ended December 31, 2023. The Company reported net sales for the year of $20.3 million, a 12% increase over the year ended December 31, 2022, resulting from 18% growth in direct-to-consumer and partner services prescription revenues, offset in part by a decline in over-the-counter product sales. The Company reported a net loss of $1.8 million for the year and negative cash f.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2023. The Company reported net sales for the third quarter of 2023 of $4.8 million, a 2% increase over the same period in 2022, resulting from growth in B2C revenue despite a 46% decline in over-the-counter segment of B2C revenue. Prescription revenues increased by 10% during the quarter. The Company reported a net loss of $299,000 for the.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2023. The Company reported net sales for the second quarter of 2023 of $5.3 million, a 27% increase over the same period in 2022, resulting from strong growth in partner services and B2C revenue. The Company reported a net loss of $477,000 for the quarter and a net loss of $825,000 for the six months ended June 30, 2023. HealthWarehouse.com, a t.
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com announces second-quarter 2021 earnings, sets annual meeting date.